DBS_Blog_DTOP_Belowtitle_336x280

Metformin for Type 2 as Good as New Expensive Drugs

EmaxHealth Health News

By Kathleen Blanchard RN for EmaxHealth.com

Johns Hopkins researchers compared newer diabetes drugs that are more costly to metformin that has been on the market for 15 years. They found metformin has fewer side effects and found no evidence that brand name newer drugs to treat type 2 diabetes are any better.

Metformin has Fewer Side Effects, Controls Blood Sugar
In the analysis most of the diabetes drugs controlled blood sugar levels, but newer diabetes drugs were found to increase the risk of dangerous side effects.

The researchers investigated diabetes drugs in 2007. As a follow-up study, they added two newer types of diabetes drugs for comparison to metformin – Byetta and Victoza that are given by injection.

Dr. Wendy Bennett, an assistant professor of medicine at Johns Hopkins University School of Medicine in Baltimore, the study’s lead author said, “Metformin continues to be an inexpensive medication and it’s very efficacious.”

To continue reading this article, crash on over here.

“LIKE” EmaxHealth news on Facebook to receive links to important articles in your Facebook feed!

Medianet DBS
The Diabetes Site is a place where people can come together to help those whose lives have been affected by diabetes. In addition to sharing inspiring stories, shopping for the cause, and signing petitions, visitors can take just a moment each day to c lick on the red button to provide much-needed support for diabetes research. Visit The Diabetes Site and click today - it's free!